Study to Characterize the Pharmacokinetics of 3 Marketed Products Containing 200 mg Guaifenesin in Healthy Volunteers.
Clinical trial NCT03643575 · COMPLETED
Trial details
- NCT number
- NCT03643575
- Sponsor
- Reckitt Benckiser Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-30
- Primary completion
- 2009-07-16
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.